secwatch.observer — SEC 8-K summary ====================================== Issuer: Outset Medical, Inc. (OM) CIK: 0001484612 Form: 8-K Filed at: 2024-08-16T23:59:59+00:00 Accession: 0000950170-24-097816 Event type: leadership Sentiment: neutral Materiality: 0.40 Item codes: 5.02 LLM model: deepseek-v4-flash:cloud@v2 Director Jim Hinrichs resigns from Outset Medical board; Hackett named Audit Chair -------------------------------------------------------------------------------- - Jim Hinrichs resigned as director and Audit Committee Chair due to affiliation with Vantive, Baxter's kidney care spin-off. - Board size reduced from 8 to 7; resignation not due to any disagreement with the company. - Patrick T. Hackett appointed Audit Committee Chair; qualifies as audit committee financial expert. - Karen Drexler succeeds Hackett as Nominating and Corporate Governance Committee Chair. Source: EDGAR index: https://www.sec.gov/Archives/edgar/data/1484612/000095017024097816/0000950170-24-097816-index.htm Primary doc: https://www.sec.gov/Archives/edgar/data/1484612/000095017024097816/om-20240815.htm HTML page: https://secwatch.observer/filing/0000950170-24-097816 License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer